CTRC Genotype

Most people never think about their pancreas until it turns on itself. Chronic pancreatitis, where the organ slowly digests and scars its own tissue, often shows up with no obvious cause, and for a real share of those cases the explanation is written in your genes.

This test reads one of the genes behind your pancreas's built-in safety brakes. If you carry certain changes in it, that brake works less well, and your odds of repeated attacks and permanent damage rise, especially alongside smoking, alcohol, or other inherited risk variants.

What This Gene Normally Does

CTRC (chymotrypsin C) is the recipe for a protective enzyme your pancreas makes. Your pancreas produces powerful digestive proteins, and one of them, trypsin, is dangerous if it activates too early inside the organ instead of in the gut. Chymotrypsin C acts like a cleanup crew, chopping up trypsin and its inactive form before they can start digesting the pancreas itself.

When a CTRC variant lowers how much of this enzyme is made, reduces how well it works, or makes it break down too fast, that safety cleanup weakens. Some variants also stress the cells that produce the enzyme. The result is a pancreas that is less able to defend itself, which is why researchers have long suspected this gene in pancreatitis.

Chronic Pancreatitis Risk

The clearest signal is for chronic pancreatitis. A pooled analysis of case-control studies found that people carrying variants that cripple the enzyme were roughly 3 to 7 times more likely to have chronic pancreatitis than people without them. The size of that jump depends heavily on which specific variant you carry.

Source: Takats et al., 2022 meta-analysis, which labels this variant p.R245W (the same change appears as p.R254W in some earlier reports). The p.V235I variant carried a similar roughly 4.5-fold increase in the same analysis.

What this means for you: a positive result shifts your baseline risk upward, but it is a shift in odds, not a diagnosis or a certainty. Carrying a high-risk variant raises the stakes of protecting your pancreas over your lifetime rather than guaranteeing disease.

The Common G60G Variant

One CTRC change, called c.180C>T (also written G60G), is common in the general population and behaves more like a dial than a switch. In a single North American cohort, having one copy raised chronic pancreatitis risk by about 36% and having two copies raised it roughly 4-fold, compared with people carrying none. A later and larger pooled analysis found somewhat higher estimates, closer to a 1.9-fold increase with one copy and a 5.3-fold increase with two.

This variant was tied to chronic pancreatitis but not to isolated recurrent acute attacks, which suggests it nudges the disease toward becoming chronic and progressive rather than triggering the first flare. It is best thought of as a modifier that influences how the disease unfolds.

Alcohol, Smoking, and Combined Risk

Genes and exposures stack. In the North American data, the c.180T version showed up more often alongside alcohol-related pancreatitis and alongside other pancreas risk genes, and smoking appeared to be a stronger companion than alcohol alone. A separate pooled analysis found the T allele was associated with roughly 1.8 times the risk of alcohol-related pancreatitis.

The picture is not uniform. A smaller Polish study did not find a link between two other CTRC changes and the development of alcoholic chronic pancreatitis. Taken together, the evidence supports using this genotype to understand a bigger risk equation that includes what you drink and whether you smoke, not as a stand-alone verdict.

Early-Onset and Childhood Disease

Some variants look more forceful in children, who by definition have not accumulated years of alcohol or tobacco exposure. In one pediatric chronic pancreatitis study, carrying two copies of the c.180T change was linked to about 23 times the risk, the p.R254W variant to about 19 times, and a recurring deletion to about 5.5 times, compared with children who did not carry them.

Yet even in young people the gene rarely acts alone. In a Japanese pediatric study, CTRC variants were uncommon and at least one affected child also carried a variant in a separate pancreas gene, reinforcing that these variants usually contribute rather than dictate.

Why One Variant Rarely Tells the Whole Story

Here is the apparent contradiction: high-risk CTRC variants raise the odds of chronic pancreatitis several-fold, yet the same variants also turn up in perfectly healthy people, and in some large cohorts, such as a Han Chinese study, CTRC variants were uncommon and other genes like SPINK1 dominated the genetic signal. Both facts are true because this is a susceptibility gene, not a deterministic one.

Chronic pancreatitis is usually oligogenic, meaning it emerges from a combination of variants in several genes plus exposures like alcohol and smoking. A CTRC variant is one weight on the scale. Its real meaning depends on the exact change you carry, whether you have one or two copies, your ancestry, and what other pancreas variants and exposures sit alongside it. Read in isolation, a single result overstates or understates your true risk.

A Result You Only Need Once

Your genotype is fixed from birth and does not change, so this is a one-time test. Once you have a reliable result, repeating the same gene test adds nothing. The value comes from carrying that answer forward and letting it shape decisions for years.

What is useful to track over time are the downstream consequences, not the gene. If you carry a higher-risk variant, the practical follow-up is periodic attention to pancreas function: markers of blood sugar such as glucose and HbA1c to catch pancreatic diabetes, and, if symptoms suggest it, tests of the pancreas's ability to digest food. A sensible starting cadence for those companion checks is a baseline now, then at least yearly if you have a history of pancreatitis or ongoing exposures.

What to Do With an Unexpected Result

A positive CTRC result is a prompt to widen the workup, not a reason to panic. Because pancreatitis risk is oligogenic, the natural next step is testing the rest of the panel, particularly PRSS1, SPINK1, and CFTR, since a variant in one of those alongside CTRC changes the risk picture substantially. Combinations of variants, or a variant plus heavy alcohol or tobacco use, carry more weight than any single finding.

If you have had unexplained or recurrent attacks, a gastroenterologist can fold this result into a full evaluation, and a genetic counselor can help interpret zygosity, ancestry, and family implications. Because the variant is inherited, a positive result is also information for your biological relatives, who may choose to be evaluated. For most people with normal pancreas function and no symptoms, the finding warrants awareness and lifestyle attention rather than immediate intervention.

When a Genetic Result Can Mislead

• Panel coverage: the assay only detects the specific variants it is designed to find, so a negative result does not rule out other rare changes in the same gene or in related pancreas genes.
• Ancestry: the frequency and meaning of variants differ by population. p.V235I and p.A73T are prominent in Indian cohorts, while p.K247_R254del and p.R254W (also written p.R245W) are reported mainly in European groups, so your background shapes how a result should be read.
• Variants of uncertain significance: an unexpected change may be reported without a clear risk interpretation, meaning its effect on your pancreas is simply not yet known.
• Clinical versus consumer testing: a variant seen on a direct-to-consumer report is not the same as a confirmed clinical result, and unexpected findings generally warrant confirmation before acting on them.